# Peter Kolchinsky Q2 2026 13F: holdings and trades

URL: https://funkfolio.com/gurus/peter-kolchinsky/2026-q2

> Peter Kolchinsky's Q2 2026 13F: RA Capital Management reported $11.5B in 84 positions, led by ASND. Every holding, and what was bought and sold that quarter.

---

## Peter Kolchinsky portfolio, Q2 2026

RA Capital Management · 13F for the quarter ending Jun 30, 2026

For Q2 2026, RA Capital Management reported $11.5B across 84 US-listed positions, led by ASND (23.8%), PBLS (6.9%) and RYTM (6.4%). Compared with its filing for Q1 2026, Peter Kolchinsky opened 16 new positions, added to 10, reduced 10 and sold out of 17; 47 positions did not change.

The largest purchase was a new position in PBLS ($791.9M); the largest sale, the sale of the whole position in DNTH ($219.2M).

This is the latest filing on file; the [main portfolio page](https://funkfolio.com/gurus/peter-kolchinsky) shows the same holdings against today's prices.

**Reported value:** $11.5B

**Positions:** 84

**In the top 10:** 60%

**Filed:** Aug 14 2026

### Key facts

- **13F portfolio value:** $11.5B Q2 2026
- **Positions:** 84
- **Largest holding:** ASND 23.8%
- **New positions:** 16
- **Sold out:** 17
- **Filed:** Aug 14, 2026

Holdings as of Jun 30, 2026 (Q2 2026), filed with the SEC on Aug 14, 2026. Changes are measured against the filing for Mar 31, 2026. [Every tracked investor's Q2 2026 13F](https://funkfolio.com/gurus/quarter/2026-q2).

### Bought and sold in Q2 2026

Peter Kolchinsky: buys and sells in Q2 2026

| Stock | Move | Shares | Size | Of portfolio |
| --- | --- | --- | --- | --- |
| [Parabilis Medicines Inc PBLS](https://funkfolio.com/stock/PBLS) | ▲ New | +28.93M | $791.9M | 6.88% |
| [Hemab Therapeutics Holdings COAG](https://funkfolio.com/stock/COAG) | ▲ New | +7.81M | $286.8M | 2.49% |
| [Dianthus Therapeutics Inc DNTH](https://funkfolio.com/stock/DNTH) | ▼ Sold out | −2.61M | $219.2M | 1.90% |
| Nuvalent Inc no ticker on file | ▼ Reduced 51% | −1.29M | $159M | 1.38% |
| [Abivax SA ABVX](https://funkfolio.com/stock/ABVX) | ▲ New | +1.13M | $150.9M | 1.31% |
| [Oruka Therapeutics Inc ORKA](https://funkfolio.com/stock/ORKA) | ▲ New | +1.55M | $148M | 1.29% |
| [Praxis Precision Medicines PRAX](https://funkfolio.com/stock/PRAX) | ▼ Sold out | −373.79K | $120.4M | 1.05% |
| [Sarepta Therapeutics Inc SRPT](https://funkfolio.com/stock/SRPT) | ▼ Sold out | −3.9M | $84.9M | 0.74% |
| [Edgewise Therapeutics Inc EWTX](https://funkfolio.com/stock/EWTX) | ▼ Reduced 20% | −2.04M | $82.7M | 0.72% |
| [Spyre Therapeutics Inc SYRE](https://funkfolio.com/stock/SYRE) | ▼ Sold out | −1.62M | $81.8M | 0.71% |
| [Artiva Biotherapeutics Inc ARTV](https://funkfolio.com/stock/ARTV) | ▲ Added 82% | +8.1M | $78.6M | 0.68% |
| [Intellia Therapeutics Inc NTLA](https://funkfolio.com/stock/NTLA) | ▲ New | +4.53M | $76.6M | 0.67% |
| [Definium Therapeutics Inc DFTX](https://funkfolio.com/stock/DFTX) | ▲ New | +1.5M | $70.6M | 0.61% |
| [Sana Biotechnology Inc SANA](https://funkfolio.com/stock/SANA) | ▲ New | +18.75M | $65.4M | 0.57% |
| [Vor Biopharma Inc VOR](https://funkfolio.com/stock/VOR) | ▼ Reduced 56% | −3M | $55.3M | 0.48% |
| [Fulcrum Therapeutics Inc FULC](https://funkfolio.com/stock/FULC) | ▼ Sold out | −6.05M | $46.4M | 0.40% |
| [Olema Pharmaceuticals Inc OLMA](https://funkfolio.com/stock/OLMA) | ▼ Sold out | −2.6M | $38.8M | 0.34% |
| [Prelude Therapeutics Inc PRLD](https://funkfolio.com/stock/PRLD) | ▲ New | +6.48M | $34.5M | 0.30% |
| [Design Therapeutics Inc DSGN](https://funkfolio.com/stock/DSGN) | ▼ Sold out | −2.97M | $31.6M | 0.27% |
| [Aclaris Therapeutics Inc ACRS](https://funkfolio.com/stock/ACRS) | ▲ Added 87% | +5.92M | $31.3M | 0.27% |
| [Q32 Bio Inc QTTB](https://funkfolio.com/stock/QTTB) | ▲ New | +2.33M | $29.7M | 0.26% |
| [Editas Medicine Inc EDIT](https://funkfolio.com/stock/EDIT) | ▲ New | +8.89M | $28.8M | 0.25% |
| [Solid Biosciences Inc SLDB](https://funkfolio.com/stock/SLDB) | ▲ Added 29% | +2.7M | $26.9M | 0.23% |
| [Geron Corp GERN](https://funkfolio.com/stock/GERN) | ▼ Reduced 33% | −20.96M | $26.8M | 0.23% |
| [Travere Therapeutics Inc TVTX](https://funkfolio.com/stock/TVTX) | ▼ Sold out | −746.84K | $22.2M | 0.19% |
| [Grail Inc GRAL](https://funkfolio.com/stock/GRAL) | ▼ Sold out | −428.27K | $22.1M | 0.19% |
| [Relmada Therapeutics Inc RLMD](https://funkfolio.com/stock/RLMD) | ▼ Sold out | −2.95M | $20.5M | 0.18% |
| [Altimmune Inc ALT](https://funkfolio.com/stock/ALT) | ▲ New | +6.5M | $19.8M | 0.17% |
| [Faeth Therapeutics Inc FTH](https://funkfolio.com/stock/FTH) | ▲ New | +722.02K | $18.1M | 0.16% |
| [Sutro Biopharma Inc STRO](https://funkfolio.com/stock/STRO) | ▼ Sold out | −715.31K | $17.8M | 0.15% |
| [Aura Biosciences Inc AURA](https://funkfolio.com/stock/AURA) | ▲ New | +2.5M | $17.8M | 0.15% |
| [Contineum Therapeutics Inc CTNM](https://funkfolio.com/stock/CTNM) | ▼ Sold out | −1.3M | $16.9M | 0.15% |
| [Inspire Med Systems Inc INSP](https://funkfolio.com/stock/INSP) | ▼ Sold out | −325.66K | $16.8M | 0.15% |
| [Seaport Therapeutics Inc SPTX](https://funkfolio.com/stock/SPTX) | ▲ New | +700K | $15.2M | 0.13% |
| [Hinge Health Inc HNGE](https://funkfolio.com/stock/HNGE) | ▼ Sold out | −364.61K | $14.1M | 0.12% |
| [GeneDx Holdings Corp WGS](https://funkfolio.com/stock/WGS) | ▼ Sold out | −209.89K | $13.5M | 0.12% |
| [Atrium Therapeutics Inc RNA](https://funkfolio.com/stock/RNA) | ▼ Sold out | −864.1K | $11.6M | 0.10% |
| [Acrivon Therapeutics Inc ACRV](https://funkfolio.com/stock/ACRV) | ▲ Added 47% | +3.89M | $6.9M | 0.06% |
| [Avalo Therapeutics Inc AVTX](https://funkfolio.com/stock/AVTX) | ▲ Added 51% | +337.03K | $6.2M | 0.05% |
| [Aktis Oncology Inc AKTS](https://funkfolio.com/stock/AKTS) | ▼ Reduced 13% | −188.68K | $6.1M | 0.05% |
| [Xencor Inc XNCR](https://funkfolio.com/stock/XNCR) | ▲ Added 7.7% | +377.04K | $6.1M | 0.05% |
| [Jatt II Acquisition Corp JATT](https://funkfolio.com/stock/JATT) | ▲ New | +500K | $5.7M | 0.05% |
| [Maplight Therapeutics Inc MPLT](https://funkfolio.com/stock/MPLT) | ▼ Sold out | −248.29K | $5M | 0.04% |
| [Amanat Acquisition Corp AMAN](https://funkfolio.com/stock/AMAN) | ▲ New | +375K | $3.8M | 0.03% |
| [Adicet Bio Inc ACET](https://funkfolio.com/stock/ACET) | ▼ Reduced 21% | −250K | $2.2M | 0.02% |
| [Werewolf Therapeutics Inc HOWL](https://funkfolio.com/stock/HOWL) | ▼ Reduced 64% | −4.29M | $1.5M | 0.01% |
| [Rezolute Inc RZLT](https://funkfolio.com/stock/RZLT) | ▲ Added 2.9% | +265.04K | $1.4M | 0.01% |
| [GH Research PLC GHRS](https://funkfolio.com/stock/GHRS) | ▼ Reduced 0.5% | −39.88K | $1.1M | 0.01% |
| [Zai Lab Ltd ZLAB](https://funkfolio.com/stock/ZLAB) | ▲ Added 0.6% | +36.27K | $689.1K | 0.01% |
| [Ovid Therapeutics Inc OVID](https://funkfolio.com/stock/OVID) | ▼ Reduced 2.0% | −213.03K | $573.1K | 0.00% |
| [Bioage Labs Inc BIOA](https://funkfolio.com/stock/BIOA) | ▲ Added 1.3% | +21K | $514.7K | 0.00% |
| [Palatin Technologies Inc PTN](https://funkfolio.com/stock/PTN) | ▼ Reduced 11% | −7.88K | $85K | 0.00% |
| [Damora Therapeutics Inc DMRA](https://funkfolio.com/stock/DMRA) | ▲ Added 0.02% | +392 | $10.2K | 0.00% |

### Holdings at the quarter's end

Peter Kolchinsky holdings, Q2 2026

| # | Stock | Sector | Share of portfolio | Value | Shares | Reported price | Held | Since Q1 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1 | [Ascendis Pharma A/S ASND](https://funkfolio.com/stock/ASND) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 23.8% | $2.7B | 10.28M | $266.72 | 9+ qtrs | — |
| 2 | [Parabilis Medicines Inc PBLS](https://funkfolio.com/stock/PBLS) | — | 6.88% | $791.9M | 28.93M | $27.37 | 1 qtr | New |
| 3 | [Rhythm Pharmaceuticals Inc RYTM](https://funkfolio.com/stock/RYTM) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 6.43% | $740.2M | 6.67M | $111.03 | 9+ qtrs | No change |
| 4 | [Vaxcyte Inc PCVX](https://funkfolio.com/stock/PCVX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 5.80% | $667M | 11.47M | $58.13 | 9+ qtrs | No change |
| 5 | [Sionna Therapeutics Inc SION](https://funkfolio.com/stock/SION) | — | 3.79% | $435.7M | 9.91M | $43.99 | 6 qtrs | No change |
| 6 | [Tyra Biosciences Inc TYRA](https://funkfolio.com/stock/TYRA) | — | 3.39% | $389.6M | 12.2M | $31.94 | 9+ qtrs | No change |
| 7 | [Edgewise Therapeutics Inc EWTX](https://funkfolio.com/stock/EWTX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 2.96% | $341M | 8.39M | $40.63 | 9+ qtrs | ▼ Reduced 20% |
| 8 | [Newamsterdam Pharma Company NAMS](https://funkfolio.com/stock/NAMS) | — | 2.81% | $323.7M | 9.55M | $33.89 | 9+ qtrs | No change |
| 9 | [Hemab Therapeutics Holdings COAG](https://funkfolio.com/stock/COAG) | — | 2.49% | $286.8M | 7.81M | $36.73 | 1 qtr | New |
| 10 | [Septerna Inc SEPN](https://funkfolio.com/stock/SEPN) | — | 2.04% | $234.3M | 7M | $33.49 | 7 qtrs | No change |
| 11 | [Bicara Therapeutics Inc BCAX](https://funkfolio.com/stock/BCAX) | — | 1.87% | $215.4M | 7.26M | $29.69 | 8 qtrs | No change |
| 12 | [Mineralys Therapeutics Inc MLYS](https://funkfolio.com/stock/MLYS) | — | 1.80% | $207.6M | 7.69M | $26.98 | 9+ qtrs | No change |
| 13 | [GH Research PLC GHRS](https://funkfolio.com/stock/GHRS) | — | 1.78% | $205.3M | 7.64M | $26.88 | 9+ qtrs | ▼ Reduced 0.5% |
| 14 | [Disc Medicine Inc IRON](https://funkfolio.com/stock/IRON) | — | 1.56% | $179.2M | 2.45M | $73.14 | 6 qtrs | No change |
| 15 | [Spyglass Pharma Inc SGP](https://funkfolio.com/stock/SGP) | — | 1.55% | $178.6M | 8.02M | $22.26 | 2 qtrs | No change |
| 16 | [Artiva Biotherapeutics Inc ARTV](https://funkfolio.com/stock/ARTV) | — | 1.51% | $174.2M | 17.96M | $9.70 | 8 qtrs | ▲ Added 82% |
| 17 | [Janux Therapeutics Inc JANX](https://funkfolio.com/stock/JANX) | — | 1.49% | $171.9M | 11.19M | $15.36 | 9+ qtrs | No change |
| 18 | [Taysha Gene Therapies Inc TSHA](https://funkfolio.com/stock/TSHA) | — | 1.39% | $160.4M | 23.56M | $6.81 | 9+ qtrs | No change |
| 19 | [BioCryst Pharmaceuticals Inc BCRX](https://funkfolio.com/stock/BCRX) | — | 1.38% | $158.3M | 15.83M | $10.00 | 3 qtrs | No change |
| 20 | [Wave Life Sciences Ltd WVE](https://funkfolio.com/stock/WVE) | — | 1.36% | $156.7M | 26.98M | $5.81 | 9+ qtrs | No change |
| 21 | Nuvalent Inc no ticker on file | — | 1.34% | $153.9M | 1.25M | $123.50 | 4 qtrs | ▼ Reduced 51% |
| 22 | [Abivax SA ABVX · ADR](https://funkfolio.com/stock/ABVX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 1.31% | $150.9M | 1.13M | $133.26 | 1 qtr | New |
| 23 | [Oruka Therapeutics Inc ORKA](https://funkfolio.com/stock/ORKA) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 1.29% | $148M | 1.55M | $95.17 | 1 qtr | New |
| 24 | [Climb Bio Inc CLYM](https://funkfolio.com/stock/CLYM) | — | 1.28% | $147.4M | 11.3M | $13.04 | 9+ qtrs | No change |
| 25 | [Solid Biosciences Inc SLDB](https://funkfolio.com/stock/SLDB) | — | 1.05% | $120.2M | 12.04M | $9.99 | 9+ qtrs | ▲ Added 29% |
| 26 | [Zai Lab Ltd ZLAB · ADR](https://funkfolio.com/stock/ZLAB) | — | 0.95% | $109.1M | 5.74M | $19.00 | 2 qtrs | ▲ Added 0.6% |
| 27 | [Ars Pharmaceuticals Inc SPRY](https://funkfolio.com/stock/SPRY) | — | 0.76% | $87M | 10.86M | $8.01 | 9+ qtrs | No change |
| 28 | [Xencor Inc XNCR](https://funkfolio.com/stock/XNCR) | — | 0.74% | $84.9M | 5.27M | $16.10 | 2 qtrs | ▲ Added 7.7% |
| 29 | [Jade Biosciences Inc JBIO](https://funkfolio.com/stock/JBIO) | — | 0.71% | $81.6M | 3.67M | $22.22 | 5 qtrs | No change |
| 30 | [Intellia Therapeutics Inc NTLA](https://funkfolio.com/stock/NTLA) | — | 0.67% | $76.6M | 4.53M | $16.92 | 1 qtr | New |
| 31 | [LB Pharmaceuticals Inc LBRX](https://funkfolio.com/stock/LBRX) | — | 0.62% | $71.7M | 2.21M | $32.46 | 4 qtrs | No change |
| 32 | [Definium Therapeutics Inc DFTX](https://funkfolio.com/stock/DFTX) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.61% | $70.6M | 1.5M | $47.04 | 1 qtr | New |
| 33 | [Aclaris Therapeutics Inc ACRS](https://funkfolio.com/stock/ACRS) | — | 0.59% | $67.3M | 12.72M | $5.29 | 2 qtrs | ▲ Added 87% |
| 34 | [4D Molecular Therapeutics FDMT](https://funkfolio.com/stock/FDMT) | — | 0.58% | $67.2M | 5.05M | $13.30 | 9+ qtrs | No change |
| 35 | [Sana Biotechnology Inc SANA](https://funkfolio.com/stock/SANA) | — | 0.57% | $65.4M | 18.75M | $3.49 | 1 qtr | New |
| 36 | [Damora Therapeutics Inc DMRA](https://funkfolio.com/stock/DMRA) | — | 0.54% | $62.4M | 2.4M | $26.01 | 2 qtrs | ▲ Added 0.02% |
| 37 | [Monopar Therapeutics Inc MNPR](https://funkfolio.com/stock/MNPR) | — | 0.54% | $61.8M | 667.21K | $92.59 | 7 qtrs | No change |
| 38 | [Acumen Pharmaceuticals Inc ABOS](https://funkfolio.com/stock/ABOS) | — | 0.49% | $56.1M | 20.99M | $2.67 | 9+ qtrs | No change |
| 39 | [Geron Corp GERN](https://funkfolio.com/stock/GERN) | — | 0.48% | $54.8M | 42.81M | $1.28 | 9+ qtrs | ▼ Reduced 33% |
| 40 | [Rezolute Inc RZLT](https://funkfolio.com/stock/RZLT) | — | 0.43% | $49.1M | 9.45M | $5.20 | 3 qtrs | ▲ Added 2.9% |
| 41 | [Evommune Inc EVMN](https://funkfolio.com/stock/EVMN) | — | 0.40% | $46.4M | 3.49M | $13.29 | 3 qtrs | No change |
| 42 | [Vor Biopharma Inc VOR](https://funkfolio.com/stock/VOR) | — | 0.38% | $44.2M | 2.4M | $18.41 | 9+ qtrs | ▼ Reduced 56% |
| 43 | [Century Therapeutics Inc IPSC](https://funkfolio.com/stock/IPSC) | — | 0.38% | $43.5M | 17.75M | $2.45 | 2 qtrs | No change |
| 44 | [Aktis Oncology Inc AKTS](https://funkfolio.com/stock/AKTS) | — | 0.37% | $42.4M | 1.31M | $32.23 | 2 qtrs | ▼ Reduced 13% |
| 45 | [Bioage Labs Inc BIOA](https://funkfolio.com/stock/BIOA) | — | 0.36% | $41M | 1.67M | $24.51 | 2 qtrs | ▲ Added 1.3% |
| 46 | [C4 Therapeutics Inc CCCC](https://funkfolio.com/stock/CCCC) | — | 0.33% | $37.4M | 8M | $4.67 | 3 qtrs | No change |
| 47 | [Mirum Pharmaceuticals Inc MIRM](https://funkfolio.com/stock/MIRM) | [Health Care](https://funkfolio.com/companies?sector=health-care) | 0.32% | $37.3M | 318.55K | $117.07 | 2 qtrs | No change |
| 48 | [Capricor Therapeutics Inc CAPR](https://funkfolio.com/stock/CAPR) | — | 0.32% | $36.3M | 1.51M | $24.08 | 3 qtrs | No change |
| 49 | [Pepgen Inc PEPG](https://funkfolio.com/stock/PEPG) | — | 0.31% | $36.1M | 20.06M | $1.80 | 9+ qtrs | No change |
| 50 | [Prelude Therapeutics Inc PRLD](https://funkfolio.com/stock/PRLD) | — | 0.30% | $34.5M | 6.48M | $5.33 | 1 qtr | New |
| 51 | [Nkarta Inc NKTX](https://funkfolio.com/stock/NKTX) | — | 0.27% | $30.6M | 10.81M | $2.83 | 9+ qtrs | No change |
| 52 | [Q32 Bio Inc QTTB](https://funkfolio.com/stock/QTTB) | — | 0.26% | $29.7M | 2.33M | $12.74 | 1 qtr | New |
| 53 | [Anteris Technologies Global AVR](https://funkfolio.com/stock/AVR) | — | 0.26% | $29.6M | 3M | $9.85 | 2 qtrs | No change |
| 54 | [Editas Medicine Inc EDIT](https://funkfolio.com/stock/EDIT) | — | 0.25% | $28.8M | 8.89M | $3.24 | 1 qtr | New |
| 55 | [Ovid Therapeutics Inc OVID](https://funkfolio.com/stock/OVID) | — | 0.25% | $28.2M | 10.5M | $2.69 | 3 qtrs | ▼ Reduced 2.0% |
| 56 | [Assembly Biosciences Inc ASMB](https://funkfolio.com/stock/ASMB) | — | 0.24% | $28M | 1.02M | $27.48 | 4 qtrs | No change |
| 57 | [Alx Oncology Holdings Inc ALXO](https://funkfolio.com/stock/ALXO) | — | 0.23% | $26.9M | 13.01M | $2.07 | 2 qtrs | No change |
| 58 | [Benitec Biopharma Inc BNTC](https://funkfolio.com/stock/BNTC) | — | 0.22% | $24.8M | 1.85M | $13.38 | 3 qtrs | No change |
| 59 | [Lenz Therapeutics Inc LENZ](https://funkfolio.com/stock/LENZ) | — | 0.21% | $23.7M | 4.18M | $5.68 | 9+ qtrs | No change |
| 60 | [Lexeo Therapeutics Inc LXEO](https://funkfolio.com/stock/LXEO) | — | 0.20% | $23.3M | 5M | $4.66 | 3 qtrs | No change |
| 61 | [Acrivon Therapeutics Inc ACRV](https://funkfolio.com/stock/ACRV) | — | 0.19% | $21.8M | 12.23M | $1.78 | 9+ qtrs | ▲ Added 47% |
| 62 | [Altimmune Inc ALT](https://funkfolio.com/stock/ALT) | — | 0.17% | $19.8M | 6.5M | $3.04 | 1 qtr | New |
| 63 | [Karyopharm Therapeutics Inc KPTI](https://funkfolio.com/stock/KPTI) | — | 0.16% | $18.7M | 1.92M | $9.77 | 2 qtrs | No change |
| 64 | [Bright Minds Biosciences Inc DRUG](https://funkfolio.com/stock/DRUG) | — | 0.16% | $18.6M | 265K | $70.20 | 2 qtrs | No change |
| 65 | [Avalo Therapeutics Inc AVTX](https://funkfolio.com/stock/AVTX) | — | 0.16% | $18.5M | 1M | $18.48 | 8 qtrs | ▲ Added 51% |
| 66 | [Onkure Therapeutics Inc-A OKUR](https://funkfolio.com/stock/OKUR) | — | 0.16% | $18.2M | 4M | $4.56 | 2 qtrs | No change |
| 67 | [Faeth Therapeutics Inc FTH](https://funkfolio.com/stock/FTH) | — | 0.16% | $18.1M | 722.02K | $25.00 | 1 qtr | New |
| 68 | [Aura Biosciences Inc AURA](https://funkfolio.com/stock/AURA) | — | 0.15% | $17.8M | 2.5M | $7.10 | 1 qtr | New |
| 69 | [Sab Biotherapeutics Inc SABS](https://funkfolio.com/stock/SABS) | — | 0.15% | $17.2M | 4.4M | $3.90 | 4 qtrs | No change |
| 70 | [Seaport Therapeutics Inc SPTX](https://funkfolio.com/stock/SPTX) | — | 0.13% | $15.2M | 700K | $21.72 | 1 qtr | New |
| 71 | [Palisade Bio Inc PALI](https://funkfolio.com/stock/PALI) | — | 0.13% | $14.9M | 7.12M | $2.09 | 3 qtrs | No change |
| 72 | [Helix Acquisition Corp HLXC](https://funkfolio.com/stock/HLXC) | — | 0.12% | $13.3M | 1.25M | $10.64 | 2 qtrs | No change |
| 73 | [Waystar Holding Corp WAY](https://funkfolio.com/stock/WAY) | [Technology](https://funkfolio.com/companies?sector=technology) | 0.09% | $10.9M | 529.4K | $20.53 | 3 qtrs | No change |
| 74 | [Equillium Inc EQ](https://funkfolio.com/stock/EQ) | — | 0.09% | $9.9M | 3.1M | $3.20 | 2 qtrs | No change |
| 75 | [Macrogenics Inc MGNX](https://funkfolio.com/stock/MGNX) | — | 0.08% | $8.6M | 1.86M | $4.62 | 2 qtrs | No change |
| 76 | Perceptive Cap Solutions no ticker on file | — | 0.07% | $8.2M | 750K | $10.88 | 9+ qtrs | No change |
| 77 | [Adicet Bio Inc ACET](https://funkfolio.com/stock/ACET) | — | 0.07% | $8.1M | 932.62K | $8.64 | 9+ qtrs | ▼ Reduced 21% |
| 78 | Newamsterdam Pharma Co NV-27 no ticker on file · WTS | — | 0.06% | $7.1M | 333.33K | $21.37 | 9+ qtrs | No change |
| 79 | [Corvus Pharmaceuticals Inc CRVS](https://funkfolio.com/stock/CRVS) | — | 0.06% | $6.7M | 450K | $14.94 | 2 qtrs | No change |
| 80 | [Rani Therapeutics Holdings-A RANI](https://funkfolio.com/stock/RANI) | — | 0.06% | $6.5M | 8.5M | $0.7604 | 3 qtrs | No change |
| 81 | [Jatt II Acquisition Corp JATT](https://funkfolio.com/stock/JATT) | — | 0.05% | $5.7M | 500K | $11.36 | 1 qtr | New |
| 82 | [Amanat Acquisition Corp AMAN](https://funkfolio.com/stock/AMAN) | — | 0.03% | $3.8M | 375K | $10.16 | 1 qtr | New |
| 83 | [Werewolf Therapeutics Inc HOWL](https://funkfolio.com/stock/HOWL) | — | 0.01% | $859.3K | 2.39M | $0.3599 | 9+ qtrs | ▼ Reduced 64% |
| 84 | [Palatin Technologies Inc PTN](https://funkfolio.com/stock/PTN) | — | 0.01% | $670.3K | 62.12K | $10.79 | 3 qtrs | ▼ Reduced 11% |

### By sector

Peter Kolchinsky portfolio by sector, Q2 2026

| Sector | Share of portfolio | Value | Positions |
| --- | --- | --- | --- |
| [Health Care](https://funkfolio.com/companies?sector=health-care) | 42.6% | $4.9B | 8 |
| [Technology](https://funkfolio.com/companies?sector=technology) | 0.09% | $10.9M | 1 |
| No sector on file | 57.3% | $6.6B | 75 |

### Questions and answers

**What did Peter Kolchinsky own in Q2 2026?**

RA Capital Management's 13F for Q2 2026 lists 84 positions worth $11.5B. The largest: ASND (23.8%), PBLS (6.9%), RYTM (6.4%), PCVX (5.8%), SION (3.8%).

**What did Peter Kolchinsky buy in Q2 2026?**

The largest purchases, by the shares bought at the quarter-end price the filing implies: PBLS (new, $791.9M), COAG (new, $286.8M), ABVX (new, $150.9M), ORKA (new, $148M), ARTV (added, $78.6M), NTLA (new, $76.6M).

**What did Peter Kolchinsky sell in Q2 2026?**

The largest sales: DNTH (sold out, $219.2M), Nuvalent Inc (reduced, $159M), PRAX (sold out, $120.4M), SRPT (sold out, $84.9M), EWTX (reduced, $82.7M), SYRE (sold out, $81.8M).

**When was this filing made?**

RA Capital Management filed its 13F for the quarter ending Jun 30, 2026 on Aug 14, 2026. A 13F is due within 45 days of the quarter's end, so the positions were already weeks old when it became public.

### Learn

- [What a 13F filing is](https://funkfolio.com/learn/superinvestors/what-is-a-13f)
- [How to read a superinvestor's portfolio](https://funkfolio.com/learn/superinvestors/how-to-read-a-13f-portfolio)
- [New, added, reduced, sold: reading 13F changes](https://funkfolio.com/learn/superinvestors/13f-changes-explained)
- [All superinvestor guides](https://funkfolio.com/learn/superinvestors)

### Cite this page

Funkfolio, “Peter Kolchinsky portfolio, Q2 2026: RA Capital Management 13F holdings”, data as of 14 August 2026. https://funkfolio.com/gurus/peter-kolchinsky/2026-q2

Underlying data: SEC EDGAR, Form 13F-HR of RA Capital Management (CIK 1346824) for the period ending Jun 30, 2026.

Source: SEC EDGAR, Form 13F-HR for RA Capital Management (CIK 1346824), period ending Jun 30, 2026, filed Aug 14, 2026. Changes compare share counts with the filing for Mar 31, 2026; a share split in between is allowed for where one is on record. “Reported price” is a position's reported value divided by its shares. The size of a buy or sell is the change in shares at that price; a position sold out is sized at its value in the previous filing, and “of portfolio” sets the size against the $11.5B reported for this quarter. “Held” counts consecutive quarterly filings up to this one, out of the 9 looked at from here back. Sectors are those of the ranked companies on this site as they stand today. Not a live portfolio and not advice.
